RPTX - Repare Therapeutics Inc
2.65
0.020 0.755%
Share volume: 1,219,919
Last Updated: 01-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$2.63
0.02
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-07-2024 | 03-03-2025 | 05-13-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 263.084 M | 235.344 M | 206.389 M | 176.506 M | 144.023 M | 126.747 M | |
| Current Assets | 254.670 M | 228.539 M | 200.403 M | 171.149 M | 140.343 M | 124.426 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 3.463 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 3.463 M | 128.303 M | 98.891 M | 68.074 M | 39.773 M | 39.779 M | |
| Total Receivables | 14.206 M | 3.571 M | 3.253 M | 0.000 | 0.000 | 0.000 | |
| Current Cash | 237.001 M | 79.820 M | 80.541 M | 84.717 M | 84.455 M | 72.825 M | |
| Total Non-current Assets | 8.414 M | 0.000 | 0.000 | 0.000 | 0.000 | 1.721 M | |
| Property Plant Equipment | 3.714 M | 3.226 M | 2.748 M | 2.294 M | 1.108 M | 0.000 | |
| Other Assets | 4.700 M | 3.579 M | 3.238 M | 3.063 M | 2.572 M | 2.321 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 263.084 M | 235.344 M | 206.389 M | 176.506 M | 144.023 M | 126.747 M | |
| Total liabilities | 31.131 M | 31.667 M | 31.430 M | 25.375 M | 18.926 M | 11.620 M | |
| Total current liabilities | 30.570 M | 31.449 M | 31.084 M | 25.287 M | 18.926 M | 11.620 M | |
| Accounts Payable | 6.825 M | 7.182 M | 10.655 M | 3.623 M | 2.284 M | 1.334 M | |
| Other liabilities | 0.000 | 218.000 K | 346.000 K | 88.000 K | 0.000 | 0.000 | |
| Current long term debt | 2.218 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 561.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 218.000 K | 346.000 K | 88.000 K | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 231.953 M | 203.677 M | 174.959 M | 151.131 M | 125.097 M | 115.127 M | |
| Common stock | 42.234 M | 558.532 M | 563.946 M | 568.865 M | 572.902 M | 576.380 M | |
| Retained earnings | -319.947 M | -354.721 M | -389.127 M | -417.798 M | -447.841 M | -461.327 M |